ENAVATE SCIENCES GP, LLC: IMNM position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ENAVATE SCIENCES GP, LLC on IMNM, newest first. How the timeline and the estimate are built.
ENAVATE SCIENCES GP, LLC held 3,613,799 IMNM shares at 2026-06-30 per its 13F-HR filed 2026-08-14.
the latest 13F is the newest step
- period ended2026-06-3013F 3,613,799 sharesChange vs previous 13F 0 shares
22.17% of the 13F portfolio, value $76,576,401.
13F-HR 0001953107-26-000012 filed by ENAVATE SCIENCES GP, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 3,613,799 sharesChange vs previous 13F -1,154,784 shares
22.48% of the 13F portfolio, value $79,033,784.
13F-HR 0001953107-26-000008 filed by ENAVATE SCIENCES GP, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 4,768,583 sharesChange vs previous 13F 0 shares
20.21% of the 13F portfolio, value $102,429,163.
13F-HR 0001953107-26-000003 filed by ENAVATE SCIENCES GP, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 4,768,583 sharesChange vs previous 13F 0 shares
17.05% of the 13F portfolio, value $55,840,107.
13F-HR 0001953107-25-000014 filed by ENAVATE SCIENCES GP, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 4,768,583 sharesChange vs previous 13F 0 shares
25.12% of the 13F portfolio, value $44,347,822.
13F-HR 0001415889-25-021852 filed by ENAVATE SCIENCES GP, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 4,768,583 sharesChange vs previous 13F +1,290,322 shares
24.18% of the 13F portfolio, value $32,092,564.
13F-HR 0001415889-25-013132 filed by ENAVATE SCIENCES GP, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 3,478,261 sharesChange vs previous 13F not available
26.53% of the 13F portfolio, value $36,939,132.
13F-HR 0001104659-25-014094 filed by ENAVATE SCIENCES GP, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).